Please provide your email address to receive an email when new articles are posted on . “The cell-free DNA is the first blood-based test with performance that is comparable to current guideline ...
Medical students and new physicians at Philadelphia-based Temple Health are trying to close the gap in CRC screening rates with a free, at-home test kit program, ABC 6 reported Oct. 8. The Access ...
cf-bDNA testing can reduce CRC incidence and mortality but is less effective and more costly than colonoscopy and FIT. The test may increase screening participation among those who avoid traditional ...
A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...
Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based colorectal cancer (CRC) screening test in the US. Exact ...
The FDA granted Check-Cap’s C-Scan an investigational device exemption March 15 that will allow the test to launch a clinical study in the U.S. The C-Scan test is a capsule-based screening technology ...
Results of multi-institutional clinical study published in peer reviewed journal ‘Cancers’ confirms efficacy of Oxford BioDynamics’ EpiSwitch ® blood-based Colorectal No-Stool Test (NST) High accuracy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback